[1]
Diaz Beveridge, R. et al. 2014. Management of Advanced Pancreatic Cancer with Gemcitabine Plus Erlotinib: Efficacy and Safety Results in Clinical Practice. JOP. Journal of the Pancreas. 15, 1 (Jan. 2014), 19–24. DOI:https://doi.org/10.6092/1590-8577/1570.